Literature DB >> 19835657

The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Melissa Lamar1, David J Libon, Angela V Ashley, James J Lah, Allan I Levey, Felicia C Goldstein.   

Abstract

Recent evidence suggests that patients with Alzheimer's disease (AD) and vascular comorbidities (VC) perform worse across measures of verbal reasoning and abstraction when compared to patients with AD alone. We performed a qualitative error analysis of Wechsler Adult Intelligence Scale-III Similarities zero-point responses in 45 AD patients with varying numbers of VC, including diabetes, hypertension, and hypercholesterolemia. Errors were scored in set if the answer was vaguely related to how the word pair was alike (e.g., dog-lion: "they can be trained") and out of set if the response was unrelated ("a lion can eat a dog"). AD patients with 2-3 VC did not differ on Similarities total score or qualitative errors from AD patients with 0-1 VC. When analyzing the group as a whole, we found that increasing numbers of VC were significantly associated with increasing out of set errors and decreasing in set errors in AD. Of the vascular diseases investigated, it was only the severity of diastolic blood pressure that significantly correlated with out of set responses. Understanding the contribution of VC to patterns of impairment in AD may provide support for directed patient and caregiver education concerning the presentation of a more severe pattern of cognitive impairment in affected individuals.

Entities:  

Mesh:

Year:  2009        PMID: 19835657      PMCID: PMC2908088          DOI: 10.1017/S1355617709990981

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  35 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Blood pressure and cognitive function in an African-American and a Caucasian-American sample: the Maine-Syracuse Study.

Authors:  Michael A Robbins; Merrill F Elias; Penelope K Elias; Marc M Budge
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

3.  Geriatric Depression Scale.

Authors:  J A Yesavage
Journal:  Psychopharmacol Bull       Date:  1988

4.  Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort.

Authors:  D W Desmond; T K Tatemichi; M Paik; Y Stern
Journal:  Arch Neurol       Date:  1993-02

5.  Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.

Authors:  Deepika Bhargava; Myron F Weiner; Linda S Hynan; Ramon Diaz-Arrastia; Anne M Lipton
Journal:  J Geriatr Psychiatry Neurol       Date:  2006-06       Impact factor: 2.680

6.  NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.

Authors:  P K Elias; M F Elias; R B D'Agostino; L A Cupples; P W Wilson; H Silbershatz; P A Wolf
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

7.  Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.

Authors:  Christiane Reitz; Bindu Patel; Ming-Xin Tang; Jennifer Manly; Richard Mayeux; Jose A Luchsinger
Journal:  J Neurol Sci       Date:  2007-02-27       Impact factor: 3.181

8.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

9.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

10.  Cognitive functioning in Alzheimer's and vascular dementia: a meta-analysis.

Authors:  J L Mathias; J Burke
Journal:  Neuropsychology       Date:  2009-07       Impact factor: 3.295

View more
  6 in total

1.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

2.  Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study.

Authors:  Lisa D Hankee; Sarah R Preis; Ryan J Piers; Alexa S Beiser; Sherral A Devine; Yulin Liu; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Exp Aging Res       Date:  2016 Jul-Sep       Impact factor: 1.645

Review 3.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

4.  How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Authors:  Rhoda Au; Ryan J Piers; Sherral Devine
Journal:  Neuropsychology       Date:  2017-11       Impact factor: 3.295

5.  High blood pressure and cognitive decline in mild cognitive impairment.

Authors:  Felicia C Goldstein; Allan I Levey; N Kyle Steenland
Journal:  J Am Geriatr Soc       Date:  2013-01-10       Impact factor: 5.562

Review 6.  Marrying Past and Present Neuropsychology: Is the Future of the Process-Based Approach Technology-Based?

Authors:  Unai Diaz-Orueta; Alberto Blanco-Campal; Melissa Lamar; David J Libon; Teresa Burke
Journal:  Front Psychol       Date:  2020-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.